Singapore health authority approves Pfizer’s Comirnaty Covid-19 vaccine for use in children aged under 5

2 months ago 129

The Ministry of Health (MOH) said today that Moderna’s Spikevax Covid-19 vaccine will be available next month, while Pfizer’s Comirnaty Covid-19 vaccine is expected to be available by the end of the year.. — Reuters pic

Follow us on Instagram, subscribe to our Telegram channel and browser alerts for the latest news you need to know.

Thursday, 29 Sep 2022 8:43 PM MYT

SINGAPORE, Sept 29 — The Health Sciences Authority (HSA) yesterday authorised the use of Pfizer’s Comirnaty Covid-19 vaccine in children aged six months through four years, making it the second vaccine approved for young children in Singapore.

The HSA said in a press release today that the vaccination regimen for the primary series in this age group consists of three 3-microgram doses.

This means that the first two doses will be administered three weeks apart, followed by a third dose to be administered at least eight weeks after the second dose.

The authority added that official vaccination recommendations on the use of this vaccine will be issued by the Expert Committee on Covid-19 Vaccination and the Ministry of Health when ready.

Last month, HSA extended the authorisation of Moderna’s two-dose Spikevax Covid-19 vaccine for children aged six months to five years.

In response to media queries, the Ministry of Health (MOH) said today that Moderna’s Spikevax Covid-19 vaccine will be available...

Read Entire Article